Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinical studies show that the Spraino low-friction shoe patch reduces severe ankle sprain injuries by over 50% in randomized controlled trials[3]. The device has also been shown to reduce harmful forces during a twist by more than 90%, prevent almost 60% of serious ankle injuries, and reduce injury time by up to 67%[2].
"In a recent 510-athlete randomized controlled trial, allocation to this 'low-friction' shoe-patch resulted in a 53% reduction of severe ankle sprain injuries."[3]
"Reduces harmful forces during a twist by more than 90%. Prevents almost 60% of serious ankle injuries. Reduces injury time by up to 67%"[2]
Products are available for both sports performance/injury prevention and for medical gait aid.
No evidence of drug development or traditional clinical trial phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spraino.